Ping An Biomedical Statistics
Total Valuation
PASW has a market cap or net worth of $19.68 million. The enterprise value is $21.98 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PASW has 124.55 million shares outstanding. The number of shares has increased by 2.66% in one year.
| Current Share Class | 124.55M |
| Shares Outstanding | 124.55M |
| Shares Change (YoY) | +2.66% |
| Shares Change (QoQ) | +5.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.05% |
| Float | 109.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.31 |
| Forward PS | n/a |
| PB Ratio | 0.54 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.76 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -47.88 |
Financial Efficiency
Return on equity (ROE) is -67.43% and return on invested capital (ROIC) is -26.96%.
| Return on Equity (ROE) | -67.43% |
| Return on Assets (ROA) | -14.67% |
| Return on Invested Capital (ROIC) | -26.96% |
| Return on Capital Employed (ROCE) | -32.43% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $685,228 |
| Profits Per Employee | -$257,437 |
| Employee Count | 7 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 116.65 |
Taxes
| Income Tax | -260,646 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.02 |
| Average Volume (20 Days) | 421,921 |
Short Selling Information
The latest short interest is 14,970, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 14,970 |
| Short Previous Month | 8,991 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, PASW had revenue of $4.80 million and -$1.80 million in losses. Loss per share was -$0.10.
| Revenue | 4.80M |
| Gross Profit | 133,372 |
| Operating Income | -2.07M |
| Pretax Income | -2.06M |
| Net Income | -1.80M |
| EBITDA | -2.06M |
| EBIT | -2.07M |
| Loss Per Share | -$0.10 |
Full Income Statement Balance Sheet
The company has $164,693 in cash and $1.47 million in debt, giving a net cash position of -$1.31 million or -$0.01 per share.
| Cash & Cash Equivalents | 164,693 |
| Total Debt | 1.47M |
| Net Cash | -1.31M |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | 6.35M |
| Book Value Per Share | 0.31 |
| Working Capital | 5.71M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -902,877 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 817 |
| Net Borrowing | -4.90M |
| Free Cash Flow | -940,254 |
| FCF Per Share | -$0.01 |
Full Cash Flow Statement Margins
Gross margin is 2.78%, with operating and profit margins of -43.05% and -37.57%.
| Gross Margin | 2.78% |
| Operating Margin | -43.05% |
| Pretax Margin | -43.00% |
| Profit Margin | -37.57% |
| EBITDA Margin | -43.04% |
| EBIT Margin | -43.05% |
| FCF Margin | n/a |